These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9134961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modulation of signal transduction in rat synaptoneurosomes by platelet activating factor.
    Domańska-Janik K, Zabłocka B.
    Mol Chem Neuropathol; 1995 May; 25(1):51-67. PubMed ID: 7546018
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
    Munoz-Cano R, Ainsua-Enrich E, Torres-Atencio I, Martin M, Sánchez-Lopez J, Bartra J, Picado C, Mullol J, Valero A.
    J Investig Allergol Clin Immunol; 2017 May; 27(3):161-168. PubMed ID: 27758758
    [Abstract] [Full Text] [Related]

  • 13. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
    De Kimpe SJ, Thiemermann C, Vane JR.
    Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
    [Abstract] [Full Text] [Related]

  • 14. Release of platelet activating factor (PAF) and eicosanoids in UVC-irradiated corneal stromal cells.
    Sheng Y, Birkle DL.
    Curr Eye Res; 1995 May; 14(5):341-7. PubMed ID: 7648859
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of platelet activating factor antagonists on cultured rat mesangial cells.
    Neuwirth R, Singhal P, Satriano JA, Braquet P, Schlondorff D.
    J Pharmacol Exp Ther; 1987 Nov; 243(2):409-14. PubMed ID: 3119816
    [Abstract] [Full Text] [Related]

  • 18. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M, Ortíz A, Lerma JL, López-Armada MJ, Mampaso F, González E, Egido J.
    Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
    [Abstract] [Full Text] [Related]

  • 19. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG, Chao W, Levine BA, Olson MS.
    Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
    [Abstract] [Full Text] [Related]

  • 20. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei.
    Grassi S, Francescangeli E, Goracci G, Pettorossi VE.
    J Neurophysiol; 1998 Jun; 79(6):3266-71. PubMed ID: 9636125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.